Drug Type siRNA |
Synonyms SYL-136001V10, SYL136001v10 |
Target |
Action inhibitors |
Mechanism NRARP inhibitors(NOTCH regulated ankyrin repeat protein inhibitors), RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Preclinical | Spain | 01 Jul 2018 |